Description: Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
Home Page: www.knowlabs.co
KNW Technical Analysis
500 Union Street
Seattle,
WA
98101
United States
Phone:
206 903 1351
Officers
| Name | Title |
|---|---|
| Mr. Ronald P. Erickson J.D. | Founder, Chairman & Treasurer |
| Mr. Phillip A. Bosua | CEO & Director |
| Mr. Peter Joseph Conley | CFO & Sr. VP of Intellectual Property |
| Mr. Leonardo Troutwein | Chief Marketing Officer |
| Dr. James H. Anderson Jr., M.D. | Chief Medical Officer and Chairman of Medical, Scientific & Regulatory Advisory Board |
| Mr. Steven T. Kent | Chief Product Officer |
| Mr. Masanori Takee | Sr. VP of Software Engineering |
Exchange: NYSE MKT
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 16.5533 |
| Price-to-Sales TTM: | 15.5731 |
| IPO Date: | 2022-09-16 |
| Fiscal Year End: | September |
| Full Time Employees: | 16 |